Effects of Tyrosine Kinase Inhibitors on Growth and Bone Metabolism in Children with Haematologic Malignancies

Cardiovasc Hematol Agents Med Chem. 2022;20(3):175-177. doi: 10.2174/1871525719666211214114229.

Authors

Athanasios Tragiannidis¹, Elpis Mantadakis²

Affiliations

¹ Childhood & Adolescent Hematology Oncology Unit, 2nd Paediatric Department, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
² Department of Paediatrics, Paediatric Hematology/Oncology Unit, Democritus University of Thrace Faculty of Medicine, Alexandroupolis, Thrace, Greece.

PMID: 34906062
DOI: 10.2174/1871525719666211214114229

No abstract available

Publication types

Editorial

MeSH terms

Child
Hematologic Neoplasms* / drug therapy
Humans
Protein Kinase Inhibitors / therapeutic use

Substances

Protein Kinase Inhibitors